<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04536428</url>
  </required_header>
  <id_info>
    <org_study_id>AJIRB-DEV-DE2-20-148</org_study_id>
    <nct_id>NCT04536428</nct_id>
  </id_info>
  <brief_title>ClearEndoclip Versus EZ Clip for Upper Gastrointestinal Ulcer Bleeding</brief_title>
  <official_title>ClearEndoclip Versus EZ Clip for the Hemostasis of Upper Gastrointestinal Ulcer Bleeding: an Open-label, Non-inferiority, Randomized, Multicenter Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ajou University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Keimyung University Dongsan Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Korea University Anam Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Cancer Center, Korea</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Nowon Eulji Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Pusan National University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Wonju Severance Christian Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Inha University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Presbyterian medical center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Ajou University School of Medicine</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      We are going to conduct a comparative study to analyze the clinical effectiveness and user&#xD;
      convenience of EZ clips that have been used in upper gastrointestinal ulcer bleeding and&#xD;
      newly developed clip (ClearEndoclip, FineMedix, Taegu) in Korea.&#xD;
&#xD;
      1) Research hypothesis and purpose&#xD;
&#xD;
        -  This study was designed to prove the hypothesis that the hemostatic effect of newly&#xD;
           developed endoscopic clip (ClearEndoclip, FineMedix, Taegu, Korea) is not inferior to&#xD;
           that of EZ clip (Olympus, Tokyo, Japan) in the treatment of hemostasis for patients who&#xD;
           visited the upper gastrointestinal ulcer bleeding.&#xD;
&#xD;
        -  This study was designed as a multi-center (9 institutions), open-labelled, randomized&#xD;
           comparative clinical trial (1:1 ratio).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      1. Design of this study&#xD;
&#xD;
             1. Stratified randomization is performed, and the variable used for stratification is&#xD;
                the patient's age (65 years or older, 65 years or less).&#xD;
&#xD;
             2. The existing clip (control) and the domestic clip (experimental group) are divided&#xD;
                by the block size randomization method of size 4 for each floor.&#xD;
&#xD;
        2. Patients and Methods&#xD;
&#xD;
             1. inclusion criteria&#xD;
&#xD;
                  -  Men and women aged 20 to 80&#xD;
&#xD;
                  -  The patients who came to the emergency room due to upper gastrointestinal&#xD;
                     bleeding with as follows: peptic ulcer with acute bleeding or protruding&#xD;
                     vascular exposure (Forrest class Ia-IIa), anastomotic vascular ulcer bleeding,&#xD;
                     bleeding from endoscopic submucosal dissection or endoscopic mucosal resection&#xD;
                     site after 24 hours&#xD;
&#xD;
                  -  American Society of Anesthesiologist (ASA) Physical Status 1 - 3&#xD;
&#xD;
                  -  Patients with adequate patient compliance and adequate geographical distance&#xD;
                     for follow-up. character&#xD;
&#xD;
             2. exclusion criteria&#xD;
&#xD;
                  -  Patients with gastrointestinal bleeding who are not recommended to clip&#xD;
                     Bleeding from a malignant tumor Hemorrhagic gastritis Angiodysplasia variceal&#xD;
                     bleeding&#xD;
&#xD;
                  -  Bleeding during endoscopic submucosal dissection or endoscopic mucosal&#xD;
                     resection&#xD;
&#xD;
                  -  Patients with insufficient clinical information&#xD;
&#xD;
                  -  Pregnant or lactating patients&#xD;
&#xD;
                  -  Patients or guardians who have not obtained informed consent&#xD;
&#xD;
             3. The number of patients&#xD;
&#xD;
                  -  The number of subjects was calculated based on a non-inferiority study&#xD;
&#xD;
                       -  The reported rate of rebleeding after hemostasis using the conventional&#xD;
                          hemoclip: about 5%.&#xD;
&#xD;
                       -  2.5% one-sided test, 80% power, and non-inferiority limit set to 10%&#xD;
&#xD;
                            -  75 subjects are required for each group, and 83 subjects are&#xD;
                               required if the drop rate is assumed to be 10%.&#xD;
&#xD;
             4. Methods&#xD;
&#xD;
                  -  After completing an informed consent form to the subjects who wish to&#xD;
                     participate in the study at the time of visit, basic clinical variables are&#xD;
                     checked.&#xD;
&#xD;
                  -  First endoscopic hemostasis is performed. In this time, EZ clip is used for&#xD;
                     the subjects assigned to the control group, and ClearEndoclip is used for the&#xD;
                     subjects assigned to the experimental group to target blood vessels in the&#xD;
                     ulcer. At the same time, clinical parameters related to hemostasis are&#xD;
                     recorded.&#xD;
&#xD;
                  -  After hemostasis is performed, rebleeding and complications are tracked up to&#xD;
                     30 days after the procedure.&#xD;
&#xD;
             5. Variables to be collected&#xD;
&#xD;
                  -  At the time of visit: age, gender, height, weight, drug use&#xD;
                     (anticoagulant/antiplatelet agents, NSAIDs, steroids), underlying diseases&#xD;
                     (cirrhosis, diabetes, end-stage renal failure, heart disease, lung disease),&#xD;
                     hematological data, hemoglobin, Complete Rockall score&#xD;
&#xD;
                  -  At the time of primary endoscopic hemostasis: location of ulcer, size of&#xD;
                     ulcer, size of exposed blood vessel (based on 2mm), forrest classification,&#xD;
                     total number of clips used, number of failed clips, usage and usage of&#xD;
                     epinephrine, procedure time (minutes) , Clip hemostasis success, treatment&#xD;
                     after clip hemostasis failure&#xD;
&#xD;
                  -  After hemostasis: rebleeding (within 7 days), number of clips and bleeding&#xD;
                     from the follow-up endoscope after 48 hours, death within 30 days, ICU&#xD;
                     hospitalization date, total hospitalization date, complications of hemostasis,&#xD;
                     Helicobacter pylori&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">August 24, 2020</start_date>
  <completion_date type="Anticipated">December 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">July 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rebleeding rate after endoscopic hemostasis</measure>
    <time_frame>upto 7 days</time_frame>
    <description>The rate of rebleeding at the site of bleeding within 7 days after the first endoscopic hemostasis, which should be identified endoscopically.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Satisfaction scores of the operator and the assistant</measure>
    <time_frame>during endoscopic procedure</time_frame>
    <description>the degree in ten-scale in terms of an endoscopic visibility to a bleeding site and the easiness of use. the minimum: 1(worst value), the maximum: 10(best)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Failure rate of clip installation</measure>
    <time_frame>during endoscopic procedure</time_frame>
    <description>Ratio of unsuccessful clips to total number of clips used</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">176</enrollment>
  <condition>Peptic Ulcer Hemorrhage</condition>
  <arm_group>
    <arm_group_label>ClearEndoclip</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This arm is a group in whom ClearEndoclip would be used for the treatment of bleeding.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>EZ clip</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This arm is a group in whom EZ clip would be used for the treatment of bleeding.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Endoscopic hemostasis with clip</intervention_name>
    <description>This intervention is performed as the following orders.&#xD;
The tip of endoscope is accessed to a bleeding site.&#xD;
The accurate visualization of bleeding site is done.&#xD;
A sheath of delivery system of clip is inserted through a working channel of endoscope.&#xD;
The end of clip is opened in front of the bleeding site. If needed, clip could be rotated to adjust to a bleeding target.&#xD;
The both ends of clip are placed on both sides of a bleeding site.&#xD;
If bleeding is still continued, additional placements of clip are tried until bleeding stops.</description>
    <arm_group_label>ClearEndoclip</arm_group_label>
    <arm_group_label>EZ clip</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Men and women aged 20 to 80&#xD;
&#xD;
          -  The patients who came to the emergency room due to upper gastrointestinal bleeding&#xD;
             with as follows: peptic ulcer with acute bleeding or protruding vascular exposure&#xD;
             (Forrest class Ia-IIa), anastomotic vascular ulcer bleeding, bleeding from endoscopic&#xD;
             submucosal dissection or endoscopic mucosal resection site after 24 hours&#xD;
&#xD;
          -  American Society of Anesthesiologist (ASA) Physical Status 1 - 3&#xD;
&#xD;
          -  Patients with adequate patient compliance and adequate geographical distance for&#xD;
             follow-up. character&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with gastrointestinal bleeding who are not recommended to clip Bleeding from&#xD;
             a malignant tumor Hemorrhagic gastritis Angiodysplasia variceal bleeding&#xD;
&#xD;
          -  Bleeding during endoscopic submucosal dissection or endoscopic mucosal resection&#xD;
&#xD;
          -  Patients with insufficient clinical information&#xD;
&#xD;
          -  Pregnant or lactating patients&#xD;
&#xD;
          -  Patients or guardians who have not obtained informed consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sun Gyo Lim</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Gastroenterology, Ajou University School of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Sun Gyo Lim</name>
      <address>
        <city>Suwon</city>
        <state>Gyeonggi</state>
        <zip>16499</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>August 6, 2020</study_first_submitted>
  <study_first_submitted_qc>August 31, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 2, 2020</study_first_posted>
  <last_update_submitted>August 31, 2020</last_update_submitted>
  <last_update_submitted_qc>August 31, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 2, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ajou University School of Medicine</investigator_affiliation>
    <investigator_full_name>Sun Gyo Lim, MD</investigator_full_name>
    <investigator_title>Associate professor</investigator_title>
  </responsible_party>
  <keyword>peptic ulcer</keyword>
  <keyword>hemorrhage</keyword>
  <keyword>stomach</keyword>
  <keyword>duodenum</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Peptic Ulcer</mesh_term>
    <mesh_term>Peptic Ulcer Hemorrhage</mesh_term>
    <mesh_term>Ulcer</mesh_term>
    <mesh_term>Hemorrhage</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemostatics</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

